Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice.
about
Angiotensin-(1-7): new perspectives in atherosclerosis treatmentAnti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP PathwayAngiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysmsEffect of Angiotensin(1-7) on Heart Function in an Experimental Rat Model of ObesityAngiotensin-(1-7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathwaysCD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2-Deficient Mice.Modulation of the action of insulin by angiotensin-(1-7).Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Therapeutic uses for Angiotensin-(1-7).The intricacies of the renin-angiotensin-system in metabolic regulation.Renin angiotensin system in liver diseases: Friend or foe?Neurodegeneration Alters Metabolic Profile and Sirt 1 Signaling in High-Fat-Induced Obese Mice.Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation.Prenatal dexamethasone and postnatal high-fat diet have a synergistic effect of elevating blood pressure through a distinct programming mechanism of systemic and adipose renin-angiotensin systems.Angiotensin-(1-7) improves non-alcoholic steatohepatitis through an adiponectin-independent mechanism.
P2860
Q26770846-CFCBAE75-ABB9-4CA7-9A07-33FD900815BEQ27322539-6BDD4E7F-CB46-4B74-952B-DD2870C007DDQ34606642-6543BCDD-32E6-4DFE-86CD-2D21B03B8870Q36387444-C7627B8D-A43D-4342-B777-FF737662F062Q37298852-807C2E10-2D43-4DCC-A5BB-A50C9AE5B53DQ37560592-71A76DE1-93CD-499C-B5E5-2479279351C5Q38180800-B278ABD2-5239-43F2-8AC9-B229ECFF4272Q38207841-B2B321A0-6E14-4E1C-8682-629234D9739EQ38819427-12B5FC16-E399-47AA-B33B-B475C31FE36AQ39020203-E20B0D4D-AA6E-4AEA-90E2-B696CE3354A2Q39360840-8E3DD59A-2898-44E3-9276-6F608B1B6B3AQ42108641-825DDDD2-0350-4DBB-ADCA-227591C4C92FQ42173694-C4039989-A034-46CC-A17F-4974C501D1C4Q47851502-FE760EEF-99AC-4A0E-AF27-B5CE2056AB4DQ52580953-E3C0BA80-A87C-48D4-9F4F-3E9F5079C765Q55023165-CA10F871-948D-4FD3-BA2E-6C1E01D11C50Q55026516-8E413441-64F7-4F50-99D5-CD75ADD39F6C
P2860
Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Oral formulation of angiotensin-
@nl
Oral formulation of angiotensi ...... osis and inflammation in mice.
@en
type
label
Oral formulation of angiotensin-
@nl
Oral formulation of angiotensi ...... osis and inflammation in mice.
@en
prefLabel
Oral formulation of angiotensin-
@nl
Oral formulation of angiotensi ...... osis and inflammation in mice.
@en
P2093
P50
P1433
P1476
Oral formulation of angiotensi ...... tosis and inflammation in mice
@en
P2093
Alanna Paraíso
Aristides Batista Maia Filho
Frederico B Sousa
John David Feltenberger
João Marcus Oliveira Andrade
Lucas Oliveira Barros
Mahboob Qureshi
Robson Augusto Souza dos Santos
P304
P356
10.1161/HYPERTENSIONAHA.111.00919
P407
P50
P577
2013-06-10T00:00:00Z